약학회지
YAKHAK HOEJI
ISSN 0377-9556 (PRINT)
ISSN 2383-9457 (ONLINE)

Table. 4.

Table. 4.

INN prescribing system, INN prescribing rate of the South Korea, USA, Japan, France, United Kingdom

South Korea USA Japan France United Kingdom
INN prescribing system Permissive Permissive Permissive Mandatory Permissive

INN prescribing rate 0.006% 85.8%* (branded generic : 4.6%) 54.4%** 29.5%*** Over 80%****

*2017 data IQVIA, National Sales Perspectives, National Prescription Audit, February 2018

** 一般名処方が全処方箋の54%に拡大、後発品使用をけん引 2019年6月審査分、点数引き上げで6割も

*** De Bruyne, F., Ponçon, A. (2018). INN or brand name drug prescriptions: a multilevel, cross-sectional study in general practice. European Journal of Clinical Pharmacology.

**** Ongoing Measures to Enhance Prescribing Efficiency Across Europe: Implications for Other Countries

Yakhak Hoeji 2021;65:183-9 https://doi.org/10.17480/psk.2021.65.3.183
© 2021 Yakhak Hoeji